Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.7.0.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenues    
Products $ 2,807,347 $ 2,266,148
Services 4,039,420 2,809,367
Total revenues 6,846,767 5,075,515
Cost of sales    
Products 1,756,849 1,552,716
Services 2,175,245 1,803,455
Total cost of sales 3,932,094 3,356,171
Gross profit 2,914,673 1,719,344
Operating expenses    
General and administrative 2,208,905 1,892,220
Selling 447,452 515,032
Research and development 180,614 218,958
Total operating expenses 2,836,971 2,626,210
Income (loss) from operations 77,702 (906,866)
Other income (expense)    
Interest and other income (expense) (1,213) 2,891
Interest expense (31,702) (42,381)
Total other expense, net (32,915) (39,490)
Income (loss) before income taxes 44,787 (946,356)
Consolidated net income (loss) 44,787 (946,356)
Less: Loss attributable to the noncontrolling interest 0 53,188
Net income (loss) attributable to Tecogen Inc. $ 44,787 $ (893,168)
Net income (loss) per share - basic (in USD per share) $ 0.00 $ (0.05)
Net income (loss) per share - diluted (in USD per share) $ 0.00 $ (0.05)
Weighted average shares outstanding - basic (shares) 20,037,795 18,478,990
Weighted average shares outstanding - diluted (shares) 20,317,142 18,478,990